Aurora Marks 1st Medical Cannabis Shipment to New Zealand Market

EDMONTON, Alberta, May 8, 2024 – PRESS RELEASE – Aurora Cannabis Inc., a Canadian-based leading global medical cannabis company, is proud to announce the arrival of Aurora branded medical cannabis products to the New Zealand market. This new line of premium dried flowers represents a significant milestone in medical cannabis accessibility in New Zealand, an emerging market poised for growth.

The initial product portfolio includes cultivars grown exclusively by Aurora, with each strain meticulously bred and cultivated to address a variety of patient needs. These carefully crafted offerings reflect Aurora's commitment to providing prescribers and patients with unparalleled quality, potency and therapeutic benefits.

"As a global leader in medical cannabis, Aurora is proud to be at the forefront of advancing patient access in New Zealand with this first and meaningful product launch," Aurora CEO Miguel Martin said. "We are thrilled to offer prescribers and patients premium dried flower options that embody our dedication to opening the world to cannabis while prioritizing patient care and well-being. We see great potential in the New Zealand market and intend to leverage symmetry with our leadership in Australia."

Equiposa, the first balanced dried cannabis product in the market, is a testament to Aurora's commitment to providing diverse options to meet patient needs. This inaugural product offering from Aurora sets a new standard for medical cannabis in New Zealand, backed by uncompromised quality and scientific rigor. Aurora strives to make a meaningful difference in the lives of patients across New Zealand, empowering them to manage their health and wellness with confidence.